Literature DB >> 7673167

Assembly, intracellular localization, and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia viruses.

G Russ1, F Esquivel, J W Yewdell, P Cresswell, T Spies, J R Bennink.   

Abstract

The transporter associated with antigen processing (TAP) transports short peptides from the cytosol to the endoplasmic reticulum, where peptides assemble with class I molecules of the major histocompatibility complex. TAP is comprised of two subunits, termed TAP1 and TAP2. We produced recombinant vaccinia viruses that direct synthesis of the TAP subunits, either individually or together. Virus-encoded TAP is rapidly and efficiently assembled (t1/2 of 5 min or less) by cells and does not spontaneously assemble in detergent extracts. By confocal immunofluorescence microscopy, TAP1 when expressed alone or with TAP2 is largely, if not exclusively, localized to the endoplasmic reticulum. Metabolic labeling with [2-3H]mannose demonstrates that TAP1 (but not TAP2) possesses Asn-linked oligosaccharides, but the lack of binding of [35S]methionine-labeled TAP to concanavalin A-agarose suggests that the glycosylated form represents a minor population of TAP1. The two subunits of the assembled complex present in detergent extracts photolabeled equally with 8-azido-[alpha-32P]ATP. Photolabeling of the two subunits was inhibited in parallel by various di- and trinucleotides, suggesting that their nucleotide binding sites function in a highly similar manner. Incubation of detergent extracts at 37 degrees C results in the rapid loss of TAP1 immunoreactivity, indicating either an unusual sensitivity to proteases or an irreversible conformation alteration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673167     DOI: 10.1074/jbc.270.36.21312

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Modulation of transporter associated with antigen processing (TAP)-mediated peptide import into the endoplasmic reticulum by flavivirus infection.

Authors:  F Momburg; A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Functional rescue of a misfolded eukaryotic ATP-binding cassette transporter by domain replacement.

Authors:  Raymond J Louie; Silvere Pagant; Ji-Young Youn; John J Halliday; Gregory Huyer; Susan Michaelis; Elizabeth A Miller
Journal:  J Biol Chem       Date:  2010-09-14       Impact factor: 5.157

3.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP.

Authors:  R Tomazin; A B Hill; P Jugovic; I York; P van Endert; H L Ploegh; D W Andrews; D C Johnson
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

Review 4.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP.

Authors:  E W Hewitt; S S Gupta; P J Lehner
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

6.  Use of chimeric proteins to investigate the role of transporter associated with antigen processing (TAP) structural domains in peptide binding and translocation.

Authors:  S Arora; P E Lapinski; M Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 7.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

8.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47.

Authors:  K Ahn; T H Meyer; S Uebel; P Sempé; H Djaballah; Y Yang; P A Peterson; K Früh; R Tampé
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

9.  The N-terminal extension domain of the C. elegans half-molecule ABC transporter, HMT-1, is required for protein-protein interactions and function.

Authors:  Sungjin Kim; Devarshi S Selote; Olena K Vatamaniuk
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

10.  Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method.

Authors:  R S Alpan; S Sparvero; A B Pardee
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.